Article citationsMore>>

Prins, M.H., Lensing, A.W.A., Brighton, T.A., Lyons, R.M., Rehm, J., Trajanovic, M., Davidson, B.L., Beyer-Westendorf, J., Pap, á.F., Berkowitz, S.D., Cohen, A.T., Kovacs, M.J., Wells, P.S. and Prandoni, P. (2014) Oral Rivaroxaban versus Enoxaparin with Vitamin K Antagonist for the Treatment of Symptomatic Venous Thromboembolism in Patients with Cancer (EINSTEIN-DVT and EINSTEIN-PE): A Pooled Subgroup Analysis of Two Randomised Controlled Trials. The Lancet Haematology, 1, e37-e46.
http://dx.doi.org/10.1016/S2352-3026(14)70018-3

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top